Lab
Roane County Medical Center
Roane County Medical Center was paid $9.24M by Medicaid between Jan 2018 and Dec 2024, across 62 billing codes. Its largest line is 99284, emergency room visit (serious) — 35% of everything it billed.
33Billing provider infoROANE COUNTY MEDICAL CENTER
HARRIMAN, TN 37748
HARRIMAN, TN 37748
33aNPI1700036696assigned 09/26/2008
33bProvider typeClinical Medical Laboratory
28Total paid$9.24M
24GClaims170,296
24DCodes billed62
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Tennessee
Rank by total paid#13 of 70
Median peer was paid$141K
This provider vs. median66×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,580 | $1.24M | |
| 2019 | 28,638 | $1.49M | |
| 2020 | 18,358 | $1.11M | |
| 2021 | 19,297 | $1.13M | |
| 2022 | 24,889 | $1.40M | |
| 2023 | 28,815 | $1.52M | |
| 2024incomplete | 21,719 | $1.35M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 35% | 13,812 | 12,785 | $3.24M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 34% | 18,838 | 17,773 | $3.13M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 4,753 | 4,324 | $1.53M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.4% | 6,358 | 6,035 | $594K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.7% | 7,034 | 6,466 | $155K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 5,410 | 5,089 | $121K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19,507 | 17,811 | $76K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,041 | 5,560 | $47K |
| 80053 | Comprehensive metabolic panel | <1% | 13,003 | 11,837 | $37K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 13,064 | 11,661 | $37K |
| 87276 | <1% | 5,625 | 5,329 | $30K | |
| 84484 | <1% | 2,694 | 2,382 | $30K |
50 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,205 | $28K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,256 | $25K |
| 87275 | <1% | 5,625 | $20K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,346 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,909 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,396 | $12K |
| 83690 | <1% | 3,451 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,581 | $11K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 789 | $10K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 167 | $10K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 524 | $10K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 236 | $7K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 225 | $7K |
| 87081 | <1% | 1,689 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 263 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 190 | $5K |
| 81001 | <1% | 5,988 | $5K | |
| 81025 | <1% | 1,613 | $4K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,558 | $3K |
| 83605 | <1% | 448 | $2K | |
| 81003 | <1% | 2,599 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 179 | $1K |
| 84702 | <1% | 77 | $989.89 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | $900.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 697 | $864.39 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 16 | $705.18 |
| 84703 | <1% | 132 | $622.33 | |
| 82077 | <1% | 92 | $408.57 | |
| 80076 | <1% | 102 | $250.51 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 258 | $239.22 |
| 87040 | <1% | 15 | $176.52 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 29 | $172.03 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 29 | $166.00 |
| 83735 | <1% | 28 | $151.76 | |
| 85610 | <1% | 156 | $142.14 | |
| 87807 | <1% | 27 | $129.81 | |
| 82805 | <1% | 13 | $110.44 | |
| 85730 | <1% | 46 | $102.48 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 78 | $96.71 |
| 87186 | <1% | 13 | $95.55 | |
| 82550 | <1% | 20 | $92.15 | |
| 82150 | <1% | 12 | $60.36 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 69 | $46.47 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 25 | $39.91 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,763 | $0.00 |
| A9270 | Non-covered item or service | 0% | 1,038 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 25 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 27 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 104 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARRINGER, RICK (VP REVENUE CYCLE)
Parent organizationCOVENANT HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| Parkwest Medical Center | Knoxville, TN | $29.88M |
| Fort Sanders Regional Medical Center | Knoxville, TN | $26.76M |
| Leconte Medical Center | Sevierville, TN | $19.05M |
| Morristown Hamblen Hospital Association | Morristown, TN | $17.83M |
| Methodist Medical Center | Oak Ridge, TN | $11.32M |
| Cumberland Medical Center, INC. | Crossville, TN | $6.06M |
| Fort Loudoun Medical Center | Lenoir City, TN | $5.86M |
| Claiborne Medical Center | Tazewell, TN | $3.41M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.